Hospital leaders tell their story about 340 B program
Congress should preserve the 340B Drug Pricing Program because of the many benefits to low-income and uninsured patients, the AHA said today in a statement submitted to the House Energy and Commerce Health Subcommittee. As part of its advocacy efforts on behalf of the 340B program, the AHA has released videos of hospital leaders describing how the program benefits their patients and communities. To watch the videos, tune in here.
Related News Articles
Headline
Hospital leaders today gathered in Washington, D.C., to urge lawmakers to reject cuts to payments for hospital care and support policies that would benefit…
Headline
Rural hospital and health system leaders today received an update on their legislative and policy priorities at an AHA Rural Hospital Policy Forum before…
Headline
Rural hospital and health system leaders today received an update on their legislative and policy priorities at an AHA Rural Hospital Policy Forum before…
Headline
The Medicare Payment Advisory Commission yesterday finalized a package of recommendations for Congress aimed at reducing the rapid growth in Part B drug…
Headline
The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act (H.R. 6174), bipartisan legislation that would limit the “orphan drug…
Headline
The Senate Special Committee on Aging today held the third in a series of hearings to investigate sudden and aggressive price spikes in older prescription…